Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

The news will intensify pressure on Pfizer Chief Executive Officer Albert Bourla, who has repeatedly pointed to the drugmaker’s pipeline as an undervalued source of future growth. Pfizer ...

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow to the company’s ambitions to compete in the rapidly growing weight-loss ...

Updated Price for Dutch TTF Natural Gas Calendar Month Futures (NYMEX: ITTX23). Charting, Price Performance, News & Related ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Company shares have fallen more than half from its pandemic highs and Chief Executive Albert Bourla is looking to turn around the company’s fortunes.

During the Q4 2024 earnings call, Pfizer CEO Albert Bourla touted the multi-year contracts for its COVID-19 portfolio and stressed, “We are confident that our COVID-19 portfolio will continue to ...